Accumulate Hims & Hers Health Inc. (HIMS) around the $30 level for a high-upside play on digital health and GLP-1 weight loss treatments as it scales toward a $6.5 billion revenue target by 2030.

Buy pullbacks in SoFi Technologies (SOFI) caused by interest rate concerns to capture an undervalued fintech leader projected to deliver 30% annual revenue growth through 2028.

In the AI infrastructure sector, IREN (IREN) is a high-conviction value pick to buy on market dips, supported by a rapid two-year payback period on hardware and strong software integration.

Investors seeking premium AI cloud computing exposure can look to Nebius Group (NBIS), which benefits from recurring agentic AI demand and hidden value in spinoff assets like ClickHouse.

Hims & Hers Health Inc. (HIMS)

• HIMS is a consumer telehealth and online pharmacy platform that bypasses traditional health insurance to provide cash-pay, direct-to-consumer medical care, personalized medications, and doctor consultations within 24 hours.
• The company is trading at an enterprise-value-to-gross-profit-over-revenue-growth ratio of 0.11, with a Rule of 40 score of 46.
• Management is guiding for $6.5 billion in revenue and $1.3 billion in adjusted EBITDA by 2030 (up from approximately $2.5 billion in current revenue), alongside a long-term adjusted EBITDA margin target of 30%.
• Key short- and medium-term growth catalysts include:
  • International market expansion by copying its US playbook into Europe, Canada, and Australia via acquisitions such as Zava and Eucalyptus.
  • Branded GLP-1 weight loss treatments (Eli Lilly and Novo Nordisk) and future distribution of next-generation drugs like Retatrutide.
  • In-house peptide production supported by the acquisition of CS Bio.
  • New clinical offerings such as hormone health (testosterone replacement therapy and menopause care), lab testing, and mental health treatments.
• The stock remains volatile (fluctuating 6% to 13% in single sessions) and is currently trading around the $30 range after pulling back from previous highs near $50.

Takeaways

• Consider HIMS as a long-term hyper-growth candidate in digital health, where the current valuation does not fully reflect international expansion, GLP-1 distribution, or high-margin product rollouts.
• Expect continued high share-price volatility due to ongoing market skepticism over its cash-pay model versus insurance-based healthcare.

IREN (IREN)

• IREN operates vertically integrated data centers and next-generation cloud infrastructure, owning both the underlying power, facilities, and bare-metal GPUs.
• The company trades at an enterprise-value-to-gross-profit-over-revenue-growth ratio of 0.08, making it cheaper on relative valuation than direct peers like Nebius.
• Key operational and financial metrics:
  • GPU installations currently deliver a return on invested capital (ROIC) around 50% with a payback period under 2 years.
  • Acquired Mirantis for $625 million alongside developing CoreDent AI, equipping the platform with Kubernetes orchestration to offer a full software stack rather than simple bare-metal server rentals.
  • High customer demand allows the company to secure up to 45% upfront prepayments on compute contracts.
• GPU assets are highly fungible and hold value better than anticipated, further supported by recent NVIDIA price increases of 15% and ongoing supply constraints.

Takeaways

• IREN represents an attractively valued play on AI compute infrastructure, offering deep discounts relative to its high return on capital and software-integrated NeoCloud strategy.
• Look for market pullbacks caused by broad sector sell-offs or CapEx concerns as potential accumulation points.

Nebius Group (NBIS)

• NBIS is an AI cloud infrastructure provider spun out from Yandex, focused on delivering high-performance GPU compute bundled with proprietary software tools.
• The stock trades at an enterprise-value-to-gross-profit-over-revenue-growth ratio of 0.14, reflecting a premium over peers due to its advanced internal software engineering capabilities.
• Value drivers and proprietary assets:
  • Strong recurring compute demand driven by agentic AI workflows and recursive model training rather than just consumer adoption.
  • Substantial venture and spinoff assets not fully reflected in the stock price, including a major stake in open-source database ClickHouse and an autonomous vehicle unit.
• The stock has risen nearly 10x from its initial post-spin levels (originally around $20–$25) but remains targeted by short sellers betting on an AI infrastructure slowdown.

Takeaways

• NBIS is well-suited for investors seeking exposure to premium AI software-and-compute stacks with additional upside from hidden venture assets like ClickHouse.
• While fundamentally strong, it trades at a higher multiple than IREN, making relative valuation a key factor to monitor when sizing positions.

SoFi Technologies (SOFI)

• SOFI is a branchless digital banking and financial services platform taking market share from legacy brick-and-mortar banks through personal loans, refinancing, checking, and investing products.
• Valuation and financial performance:
  • Trades at 1.38x forward revenue and an enterprise-value-to-gross-profit-over-revenue-growth ratio of 0.07.
  • Achieves a Rule of 40 score between 67 and 70, with forward revenue growth projected at 32%.
  • Management guides for $7.8 billion in revenue by 2028 (representing a 30% CAGR) and long-term adjusted EBITDA margins around 30% to 35%.
  • Platform members are expanding at a 37% CAGR, continuously increasing the number of products utilized per user.
• Interest rate sensitivity:
  • Revenue remains composed of roughly 60% lending and 40% fees, causing the stock to trade down on hawkish Federal Reserve sentiment.
  • A reduction in benchmark interest rates serves as a massive operational catalyst by lowering consumer borrowing costs and driving loan origination volumes.

Takeaways

• SOFI is an asymmetric financial-technology opportunity trading near multi-year valuation lows despite steady 30%+ revenue and user growth.
• Any weakness caused by short-term interest rate fears offers a favorable entry point ahead of eventual rate-cutting cycles and loan origination acceleration.